Novel insights into the association between genetically proxied inhibition of proprotein convertase subtilisin/kexin type 9 and risk of sarcopenia

Novel insights into the association between genetically proxied inhibition of proprotein convertase subtilisin/kexin type 9 and risk of sarcopenia

Abstract Background The effects of lipid‐lowering drugs [including statins, ezetimibe, and proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors] on hyperlipidaemia have been established. Some may have treatment effects beyond their reported properties, offering potential opportunities fo...

Full description

Saved in:
Bibliographic Details
Main Authors: Hongyan Jiang, Lulu Li, Xue Zhang, Jia He, Chuanhuai Chen, Ruimin Sun, Ying Chen, Lijuan Xia, Lei Wen, Yunxiang Chen, Junxiu Liu, Lijiang Zhang, Wanqiang Lv
Format: Article
Language:English
Published: Wiley 2024-12-01
Series:Journal of Cachexia, Sarcopenia and Muscle
Subjects:
Mendelian randomization
Older people
Proprotein convertase subtilisin/kexin type 9
Sarcopenia
Therapeutic target prediction
Online Access:https://doi.org/10.1002/jcsm.13575
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doi.org/10.1002/jcsm.13575

Similar Items